Back to Search
Start Over
Fidaxomicin: Cost Considerations for the Treatment of Clostridium difficile Infection.
- Source :
-
Infectious Disease Alert . Sep2011 Supplement, p19-21. 3p. - Publication Year :
- 2011
-
Abstract
- The article discusses the cost considerations related to the use drugs for the treatment of Clostridium difficile infection (CDI). It presents an overview of clinical practice guidelines for CDI made by the Society of Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA). It examines the average wholesale pricing of drugs for CDI such as vancomycin and fidaxomicin and their efficacy in patients.
- Subjects :
- *MEDICAL care costs
*CLOSTRIDIOIDES difficile
*VANCOMYCIN
*DRUG efficacy
*SOCIETIES
Subjects
Details
- Language :
- English
- ISSN :
- 07397348
- Database :
- Academic Search Index
- Journal :
- Infectious Disease Alert
- Publication Type :
- Periodical
- Accession number :
- 66423899